Sun Pharma Advanced Research Second Quarter 2025 Earnings 3.31 loss per share
| INCR Stock | USD 1.53 0.03 1.92% |
Slightly above 62% of INC Research's investor base is looking to short. The analysis of the overall investor sentiment regarding INC Research Holdings suggests that many traders are alarmed. INC Research's investing sentiment overview a quick insight into current market opportunities from investing in INC Research Holdings. Many technical investors use INC Research Holdings stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Sun Pharma Advanced Research Second Quarter 2025 Results Key Financial Results Revenue 129.0m down ...
Read at simplywall.st
 |
INC Research Fundamental Analysis
We analyze INC Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of INC Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of INC Research based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
INC Research is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
INC Research Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with INC Research stock to make a market-neutral strategy. Peer analysis of INC Research could also be used in its relative valuation, which is a method of valuing INC Research by comparing valuation metrics with similar companies.
Peers
INC Research Related Equities
| RGC | Regencell Bioscience | 3.66 | ||||
| VRNOF | Verano Holdings | 1.52 | ||||
| PCRX | Pacira BioSciences, | 0.27 | ||||
| PAHC | Phibro Animal | 0.16 | ||||
| PBH | Prestige Brand | 1.78 | ||||
| COLL | Collegium Pharmaceutical | 1.93 | ||||
| AYRWF | AYR Strategies | 4.55 | ||||
| IXHL | Incannex Healthcare | 14.81 |
Additional Tools for INC Stock Analysis
When running INC Research's price analysis, check to measure INC Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INC Research is operating at the current time. Most of INC Research's value examination focuses on studying past and present price action to predict the probability of INC Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INC Research's price. Additionally, you may evaluate how the addition of INC Research to your portfolios can decrease your overall portfolio volatility.